Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8694-8701
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8694
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8694
Group | n | Time to recovery of white blood cells | Time to recovery of body temperature | Time to disappearance of cough and expectoration | Time to disappearance of rales |
Study | 37 | 6.79 ± 2.09 | 4.15 ± 1.08 | 6.19 ± 1.56 | 6.68 ± 1.43 |
Control | 37 | 8.89 ± 2.32 | 5.81 ± 1.33 | 8.77 ± 2.11 | 8.69 ± 2.12 |
t | 4.091 | 5.894 | 5.981 | 4.781 | |
P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Wang XX, Ma CT, Jiang YX, Ge YJ, Liu FY, Xu WG. Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients. World J Clin Cases 2021; 9(29): 8694-8701
- URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8694.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8694